This review aims to examine economic evaluations of varenicline, to compare the reported cost-effectiveness of varenicline with that of treatments for major smoking-related diseases and to evaluate the findings for decision making.
Senior Health Technology and Clinical Evidence Reviewer, Head of European Operations, RTI Health Solutions, Williams House, Manchester Science Park, Manchester, UK. ezimovetz@rti.org
